Trial Profile
Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 Jan 2023
Price :
$35
*
At a glance
- Drugs Ferric carboxymaltose (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Acronyms ITACS
- 09 Jan 2023 Planned End Date changed from 1 Oct 2023 to 1 Jun 2024.
- 09 Jan 2023 Planned primary completion date changed from 1 Apr 2023 to 1 Dec 2023.
- 08 Oct 2020 Planned End Date changed from 1 Oct 2020 to 1 Oct 2023.